Flexible Ureteroscopy Versus ESWL in the Management of Lower Calyceal Stones
1 other identifier
interventional
60
1 country
1
Brief Summary
to assess safety, efficacy of Flexible ureteroscopy (FURS) holmium:YAG laser lithotripsy (LL) compared to extracorporeal shockwave lithotripsy (ESWL) in management of lower calyceal stones (LC) stones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 14, 2016
CompletedFirst Posted
Study publicly available on registry
January 20, 2016
CompletedJanuary 20, 2016
January 1, 2016
2 years
January 14, 2016
January 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stone free rate
no stone fragments or having fragments \<3mm
3 months
Secondary Outcomes (1)
Complications
3 years
Study Arms (2)
Ureteroscopy
ACTIVE COMPARATORIntervention: Flexible ureteroscopy for removal of lower calyceal stones using holmium:YAG laser lithotripsy
Shockwave lithotripsy
ACTIVE COMPARATORIntervention: Shockwave lithotripsy for lithotripsy of lower calyceal stones using Siemens Lithostar Lithotriptor
Interventions
In Group A patients, Karl Storz Flex-X 7.5, FURS with a 365 µm laser fiber.
In Group B patients, a Siemens Lithostar Lithotriptor
Eligibility Criteria
You may qualify if:
- unilateral
- radiopaque stone(s)
- \< 2 cm
- located in the lower calyx.
You may not qualify if:
- Bleeding tendency
- distal obstruction
- Anomalies of the urinary tract
- Solitary kidney
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University Hospitals
Cairo, 12222, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammed S ElSheemy, M.D
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
January 14, 2016
First Posted
January 20, 2016
Study Start
May 1, 2010
Primary Completion
May 1, 2012
Study Completion
May 1, 2015
Last Updated
January 20, 2016
Record last verified: 2016-01